Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Tilray Brands Community
NasdaqGS:TLRY Community
2
Narratives
written by author
0
Comments
on narratives written by author
156
Fair Values set
on narratives written by author
Community Investing Ideas
Tilray Brands
Popular
Undervalued
Overvalued
Tilray Brands
AN
AnalystHighTarget
Consensus Narrative from 9 Analysts
Secular Legalization And Wellness Trends Will Transform EU Cannabis Industry
Key Takeaways Tilray is set to dominate European medical cannabis through unique assets, distribution, and rapid market expansion, driving sustained revenue and margin growth. Broad product diversification and M&A agility position Tilray to capture new health, wellness, and beverage opportunities as global cannabis adoption increases.
View narrative
US$1.50
FV
26.0% undervalued
intrinsic discount
5.21%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Tilray Brands
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Expanding European Cannabis Markets Will Unlock Global Wellness Potential
Key Takeaways Expansion in Europe and category diversification are driving strong growth, margin improvements, and long-term revenue potential as global cannabis markets develop. Operational efficiencies and a solid financial position support continued cost optimization, strategic acquisitions, and international market entry for ongoing earnings growth.
View narrative
US$0.93
FV
19.6% overvalued
intrinsic discount
4.62%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
76
users have followed this narrative
14 days ago
author updated this narrative
Your Valuation for
TLRY
TLRY
Tilray Brands
Your Fair Value
US$
Current Price
US$1.11
38.3% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-2b
1b
2015
2018
2021
2024
2025
2027
2030
Revenue US$1.0b
Earnings US$149.6m
Advanced
Set Fair Value